Journal of Cardiovascular Imaging

  • 제22권4호
  • /
  • Pages.173-179
  • /
  • 2014
  • /
  • 2586-7210(pISSN)
  • /
  • 2586-7296(eISSN)
한국심초음파학회 (Korean Society of Echocardiography)
권호 표지
DOI QR코드

DOI QR Code

ROLE OF ECHOCARDIOGRAPHY IN THE MANAGEMENT OF CARDIAC DISEASE IN WOMEN

  • Shim, Wan Joo (Division of Cardiology, Korea University Anam Hospital)
  • 투고 : 2014.10.29
  • 심사 : 2014.11.27
  • 발행 : 2014.12.27
⟨ 이전 논문 다음 논문 ⟩

초록

The widespread use of echocardiography has contributed to the early recognition of several distinct cardiac diseases in women. During pregnancy, safe monitoring of the disease process, as well as a better understanding of hemodynamics, is possible. During the use of potentially cardiotoxic drugs for breast cancer chemotherapy, echocardiographic patient monitoring is vital. Compared to men, the addition of an imaging modality to routine electrocardiogram monitoring during stress testing is more informative for diagnosing coronary disease in women. This review briefly discusses the role of echocardiography in the management of several women-specific cardiac diseases where echocardiography plays a pivotal role in disease management.

키워드

참고문헌

  1. Statistics Korea. 2013 Death statistics. Deajeon: Statistics Korea;2014.
  2. Bilhartz TD, Bilhartz PA, Bilhartz TN, Bilhartz RD. Making use of a natural stress test: pregnancy and cardiovascular risk. J Womens Health (Larchmt) 2011;20:695-701. https://doi.org/10.1089/jwh.2010.2291
  3. Miller VM, Garovic VD, Kantarci K, Barnes JN, Jayachandran M, Mielke MM, Joyner MJ, Shuster LT, Rocca WA. Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause. Biol Sex Differ 2013;4:6. https://doi.org/10.1186/2042-6410-4-6
  4. Wenger NK. Gender disparity in cardiovascular disease: bias or biology? Expert Rev Cardiovasc Ther 2012;10:1401-11. https://doi.org/10.1586/erc.12.133
  5. Ain DL, Narula J, Sengupta PP. Cardiovascular imaging and diagnostic procedures in pregnancy. Cardiol Clin 2012;30:331-41. https://doi.org/10.1016/j.ccl.2012.05.002
  6. Savu O, Jurcut R, Giusca S, van Mieghem T, Gussi I, Popescu BA, Ginghina C, Rademakers F, Deprest J, Voigt JU. Morphological and functional adaptation of the maternal heart during pregnancy. Circ Cardiovasc Imaging 2012;5:289-97. https://doi.org/10.1161/CIRCIMAGING.111.970012
  7. Cornette J, Ruys TP, Rossi A, Rizopoulos D, Takkenberg JJ, Karamermer Y, Opic P, Van den Bosch AE, Geleijnse ML, Duvekot JJ, Steegers EA, Roos-Hesselink JW. Hemodynamic adaptation to pregnancy in women with structural heart disease. Int J Cardiol 2013;168:825-31. https://doi.org/10.1016/j.ijcard.2012.10.005
  8. Bamfo JE, Kametas NA, Nicolaides KH, Chambers JB. Maternal left ventricular diastolic and systolic long-axis function during normal pregnancy. Eur J Echocardiogr 2007;8:360-8. https://doi.org/10.1016/j.euje.2006.12.004
  9. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E, Regitz-Zagrosek V, Schaufelberger M, Tavazzi L, van Veldhuisen DJ, Watkins H, Shah AJ, Seferovic PM, Elkayam U, Pankuweit S, Papp Z, Mouquet F, McMurray JJ; Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail 2010;12:767-78. https://doi.org/10.1093/eurjhf/hfq120
  10. Karaye KM, Henein MY. Peripartum cardiomyopathy: a review article. Int J Cardiol 2013;164:33-8. https://doi.org/10.1016/j.ijcard.2011.11.069
  11. Elkayam U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J Am Coll Cardiol 2011;58:659-70. https://doi.org/10.1016/j.jacc.2011.03.047
  12. Goland S, Bitar F, Modi K, Safirstein J, Ro A, Mirocha J, Khatri N, Elkayam U. Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail 2011;17:426-30. https://doi.org/10.1016/j.cardfail.2011.01.007
  13. Vitarelli A, Capotosto L. Role of echocardiography in the assessment and management of adult congenital heart disease in pregnancy. Int J Cardiovasc Imaging 2011;27:843-57. https://doi.org/10.1007/s10554-010-9750-9
  14. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, Kells CM, Bergin ML, Kiess MC, Marcotte F, Taylor DA, Gordon EP, Spears JC, Tam JW, Amankwah KS, Smallhorn JF, Farine D, Sorensen S; Cardiac Disease in Pregnancy (CARPREG) Investigators. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515-21. https://doi.org/10.1161/hc3001.093437
  15. Brickner ME. Cardiovascular management in pregnancy: congenital heart disease. Circulation 2014;130:273-82. https://doi.org/10.1161/CIRCULATIONAHA.113.002105
  16. European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM), Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R, Ferreira R, Foidart JM, Gibbs JS, Gohlke-Baerwolf C, Gorenek B, Iung B, Kirby M, Maas AH, Morais J, Nihoyannopoulos P, Pieper PG, Presbitero P, Roos-Hesselink JW, Schaufelberger M, Seeland U, Torracca L; ESC Committee for Practice Guidelines. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147-97. https://doi.org/10.1093/eurheartj/ehr218
  17. Asfour V, Murphy MO, Attia R. Is vaginal delivery or caesarean section the safer mode of delivery in patients with adult congenital heart disease? Interact Cardiovasc Thorac Surg 2013;17:144-50. https://doi.org/10.1093/icvts/ivt110
  18. Omnes S, Jondeau G, Detaint D, Dumont A, Yazbeck C, Guglielminotti J, Luton D, Azria E. Pregnancy outcomes among women with Marfan syndrome. Int J Gynaecol Obstet 2013;122:219-23. https://doi.org/10.1016/j.ijgo.2013.04.013
  19. Lotrionte M, Biondi-Zoccai G, Abbate A, Lanzetta G, D'Ascenzo F, Malavasi V, Peruzzi M, Frati G, Palazzoni G. Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity. Am J Cardiol 2013;112:1980-4. https://doi.org/10.1016/j.amjcard.2013.08.026
  20. Nolan MT, Lowenthal RM, Venn A, Marwick TH. Chemotherapy-related cardiomyopathy: a neglected aspect of cancer survivorship. Intern Med J 2014;44:939-50. https://doi.org/10.1111/imj.12532
  21. Lipshultz SE, Adams MJ, Colan SD, Constine LS, Herman EH, Hsu DT, Hudson MM, Kremer LC, Landy DC, Miller TL, Oeffinger KC, Rosenthal DN, Sable CA, Sallan SE, Singh GK, Steinberger J, Cochran TR, Wilkinson JD; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Basic Cardiovascular Sciences, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Radiolo. Long-term cardiovascular toxicity in children, adolescents, and young adults who receive cancer therapy: pathophysiology, course, monitoring, management, prevention, and research directions: a scientific statement from the American Heart Association. Circulation 2013;128:1927-95. https://doi.org/10.1161/CIR.0b013e3182a88099
  22. Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, Criscitiello C, Goldhirsch A, Cipolla C, Roila F; ESMO Guidelines Working Group. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol 2012;23 Suppl 7:vii155-66.
  23. Telli ML, Hunt SA, Carlson RW, Guardino AE. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol 2007;25:3525-33. https://doi.org/10.1200/JCO.2007.11.0106
  24. Choueiri TK, Mayer EL, Je Y, Rosenberg JE, Nguyen PL, Azzi GR, Bellmunt J, Burstein HJ, Schutz FA. Congestive heart failure risk in patients with breast cancer treated with bevacizumab. J Clin Oncol 2011;29:632-8. https://doi.org/10.1200/JCO.2010.31.9129
  25. Kalam K, Marwick TH. Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis. Eur J Cancer 2013;49:2900-9. https://doi.org/10.1016/j.ejca.2013.04.030
  26. Sawaya H, Sebag IA, Plana JC, Januzzi JL, Ky B, Tan TC, Cohen V, Banchs J, Carver JR, Wiegers SE, Martin RP, Picard MH, Gerszten RE, Halpern EF, Passeri J, Kuter I, Scherrer-Crosbie M. Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 2012;5:596-603. https://doi.org/10.1161/CIRCIMAGING.112.973321
  27. Truong J, Yan AT, Cramarossa G, Chan KK. Chemotherapy-induced cardiotoxicity: detection, prevention, and management. Can J Cardiol 2014;30:869-78. https://doi.org/10.1016/j.cjca.2014.04.029
  28. Altena R, Perik PJ, van Veldhuisen DJ, de Vries EG, Gietema JA. Cardiovascular toxicity caused by cancer treatment: strategies for early detection. Lancet Oncol 2009;10:391-9. https://doi.org/10.1016/S1470-2045(09)70042-7
  29. Thavendiranathan P, Grant AD, Negishi T, Plana JC, Popovic ZB, Marwick TH. Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol 2013;61:77-84. https://doi.org/10.1016/j.jacc.2012.09.035
  30. Villarraga HR, Herrmann J, Nkomo VT. Cardio-oncology: role of echocardiography. Prog Cardiovasc Dis 2014;57:10-8. https://doi.org/10.1016/j.pcad.2014.05.002
  31. Thavendiranathan P, Poulin F, Lim KD, Plana JC, Woo A, Marwick TH. Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol 2014;63(25 Pt A):2751-68. https://doi.org/10.1016/j.jacc.2014.01.073
  32. Lotrionte M, Cavarretta E, Abbate A, Mezzaroma E, De Marco E, Di Persio S, Loperfido F, Biondi-Zoccai G, Frati G, Palazzoni G. Temporal changes in standard and tissue Doppler imaging echocardiographic parameters after anthracycline chemotherapy in women with breast cancer. Am J Cardiol 2013;112:1005-12. https://doi.org/10.1016/j.amjcard.2013.05.038
  33. National Heart, Lung, and Blood Institute. Morbidity and mortality: 2012 chart book on cardiovascular, lung, and blood diseases. p.28-33. Available at: https://www.nhlbi.nih.gov/files/docs/research/2012_Chart-Book_508.pdf.
  34. Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98. https://doi.org/10.1056/NEJMsa053935
  35. de Boer SP, Roos-Hesselink JW, van Leeuwen MA, Lenzen MJ, van Geuns RJ, Regar E, van Mieghem NM, van Domburg R, Zijlstra F, Serruys PW, Boersma E. Excess mortality in women compared to men after PCI in STEMI: an analysis of 11,931 patients during 2000-2009. Int J Cardiol 2014;176:456-63. https://doi.org/10.1016/j.ijcard.2014.07.091
  36. Vaccarino V, Parsons L, Peterson ED, Rogers WJ, Kiefe CI, Canto J. Sex differences in mortality after acute myocardial infarction: changes from 1994 to 2006. Arch Intern Med 2009;169:1767-74.
  37. Sanders GD, Patel MR, Chatterjee R, Ross AK, Bastian LA, Coeytaux RR, Heidenfelder BL, Musty MD, Dolor RJ. Noninvasive technologies for the diagnosis of coronary artery disease in women: future research needs: identification of future research needs from comparative effectiveness review No. 58. Rockville: Agency for Healthcare Research and Quality (US);2013. Report No.: 13-EHC072-EF.
  38. Wenger NK. Women and coronary heart disease: a century after Herrick: understudied, underdiagnosed, and undertreated. Circulation 2012;126:604-11. https://doi.org/10.1161/CIRCULATIONAHA.111.086892
  39. Shaw LJ, Bairey Merz CN, Pepine CJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Mankad S, Sharaf BL, Rogers WJ, Wessel TR, Arant CB, Pohost GM, Lerman A, Quyyumi AA, Sopko G; WISE Investigators. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. J Am Coll Cardiol 2006;47(3 Suppl):S4-20. https://doi.org/10.1016/j.jacc.2005.01.072
  40. Gulati M, Cooper-DeHoff RM, McClure C, Johnson BD, Shaw LJ, Handberg EM, Zineh I, Kelsey SF, Arnsdorf MF, Black HR, Pepine CJ, Merz CN. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. Arch Intern Med 2009;169:843-50. https://doi.org/10.1001/archinternmed.2009.50
  41. Kwok Y, Kim C, Grady D, Segal M, Redberg R. Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 1999;83:660-6. https://doi.org/10.1016/S0002-9149(98)00963-1
  42. Gulati M, Arnsdorf MF, Shaw LJ, Pandey DK, Thisted RA, Lauderdale DS, Wicklund RH, Al-Hani AJ, Black HR. Prognostic value of the duke treadmill score in asymptomatic women. Am J Cardiol 2005;96:369-75. https://doi.org/10.1016/j.amjcard.2005.03.078
  43. Alexander KP, Shaw LJ, Shaw LK, Delong ER, Mark DB, Peterson ED. Value of exercise treadmill testing in women. J Am Coll Cardiol 1998;32:1657-64. https://doi.org/10.1016/S0735-1097(98)00451-3
  44. Shaw LJ, Vasey C, Sawada S, Rimmerman C, Marwick TH. Impact of gender on risk stratification by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J 2005;26:447-56. https://doi.org/10.1093/eurheartj/ehi102
  45. Marwick TH, Anderson T, Williams MJ, Haluska B, Melin JA, Pashkow F, Thomas JD. Exercise echocardiography is an accurate and cost-efficient technique for detection of coronary artery disease in women. J Am Coll Cardiol 1995;26:335-41. https://doi.org/10.1016/0735-1097(95)80004-Z
  46. Vavas E, Hong SN, Rosen SE, Mieres JH. Noninvasive diagnostic techniques for coronary disease in women. Clin Cardiol 2012;35:149-55. https://doi.org/10.1002/clc.21953
  47. Mieres JH, Shaw LJ, Arai A, Budoff MJ, Flamm SD, Hundley WG, Marwick TH, Mosca L, Patel AR, Quinones MA, Redberg RF, Taubert KA, Taylor AJ, Thomas GS, Wenger NK; Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation 2005;111:682-96. https://doi.org/10.1161/01.CIR.0000155233.67287.60
  48. Dodi C, Cortigiani L, Masini M, Olivotto I, Azzarelli A, Nannini E. The incremental prognostic value of pharmacological stress echo over exercise electrocardiography in women with chest pain of unknown origin. Eur Heart J 2001;22:145-52. https://doi.org/10.1053/euhj.2000.2321
  49. Arruda-Olson AM, Juracan EM, Mahoney DW, McCully RB, Roger VL, Pellikka PA. Prognostic value of exercise echocardiography in 5,798 patients: is there a gender difference? J Am Coll Cardiol 2002;39:625-31. https://doi.org/10.1016/S0735-1097(01)01801-0
  50. Metz LD, Beattie M, Hom R, Redberg RF, Grady D, Fleischmann KE. The prognostic value of normal exercise myocardial perfusion imaging and exercise echocardiography: a meta-analysis. J Am Coll Cardiol 2007;49:227-37. https://doi.org/10.1016/j.jacc.2006.08.048
  51. Shaw LJ, Tandon S, Rosen S, Mieres JH. Evaluation of suspected ischemic heart disease in symptomatic women. Can J Cardiol 2014;30:729-37. https://doi.org/10.1016/j.cjca.2013.09.019
  52. Camara EJ, Oliveira MM, Ribeiro FM. Baseline echocardiographic predictors of dynamic intraventricular obstruction of the left ventricle during dobutamine stress echocardiogram. Echocardiography 2009;26:1195-203. https://doi.org/10.1111/j.1540-8175.2009.00953.x
  53. Dawn B, Paliwal VS, Raza ST, Mastali K, Longaker RA, Stoddard MF. Left ventricular outflow tract obstruction provoked during dobutamine stress echocardiography predicts future chest pain, syncope, and near syncope. Am Heart J 2005;149:908-16. https://doi.org/10.1016/j.ahj.2004.07.029
  54. Pellikka PA, Oh JK, Bailey KR, Nichols BA, Monahan KH, Tajik AJ. Dynamic intraventricular obstruction during dobutamine stress echocardiography. A new observation. Circulation 1992;86:1429-32. https://doi.org/10.1161/01.CIR.86.5.1429
  55. Bairey Merz CN, Shaw LJ, Reis SE, Bittner V, Kelsey SF, Olson M, Johnson BD, Pepine CJ, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Lerman A, Quyyumi AA, Sopko G; WISE Investigators. Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. J Am Coll Cardiol 2006;47(3 Suppl):S21-9. https://doi.org/10.1016/j.jacc.2004.12.084
  56. Shaw LJ, Shaw RE, Merz CN, Brindis RG, Klein LW, Nallamothu B, Douglas PS, Krone RJ, McKay CR, Block PC, Hewitt K, Weintraub WS, Peterson ED; American College of Cardiology-National Cardiovascular Data Registry Investigators. Impact of ethnicity and gender differences on angiographic coronary artery disease prevalence and inhospital mortality in the American College of Cardiology-National Cardiovascular Data Registry. Circulation 2008;117:1787-801. https://doi.org/10.1161/CIRCULATIONAHA.107.726562
  57. Pepine CJ, Anderson RD, Sharaf BL, Reis SE, Smith KM, Handberg EM, Johnson BD, Sopko G, Bairey Merz CN. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 2010;55:2825-32. https://doi.org/10.1016/j.jacc.2010.01.054
  58. Dhawan SS, Corban MT, Nanjundappa RA, Eshtehardi P, McDaniel MC, Kwarteng CA, Samady H. Coronary microvascular dysfunction is associated with higher frequency of thin-cap fibroatheroma. Atherosclerosis 2012;223:384-8. https://doi.org/10.1016/j.atherosclerosis.2012.05.034
  59. Nihoyannopoulos P, Kaski JC, Crake T, Maseri A. Absence of myocardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol 1991;18:1463-70. https://doi.org/10.1016/0735-1097(91)90676-Z
  60. Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A. Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X. Am J Cardiol 1987;60:508-12. https://doi.org/10.1016/0002-9149(87)90295-5
  61. Prescott E, Abildstrom SZ, Aziz A, Merz NB, Gustafsson I, Halcox J, Hansen HS, Hansen PR, Kastrup J, Michelsen M, Mygind ND, Ong P, Pena A, Rosengren A, Sechtem U, Sogaard P. Improving diagnosis and treatment of women with angina pectoris and microvascular disease: the iPOWER study design and rationale. Am Heart J 2014;167:452-8. https://doi.org/10.1016/j.ahj.2014.01.003
  62. Cadeddu C, Nocco S, Deidda M, Pau F, Colonna P, Mercuro G. Altered transmural contractility in postmenopausal women affected by cardiac syndrome X. J Am Soc Echocardiogr 2014;27:208-14. https://doi.org/10.1016/j.echo.2013.09.014

피인용 문헌

  1. Echocardiography in Pregnancy: Part 2 vol.18, pp.9, 2016, https://doi.org/10.1007/s11886-016-0761-6
  2. Algorithm of echocardiography in pregnant women vol.2018, pp.12, 2014, https://doi.org/10.15829/1560-4071-2018-12-75-83